8-KEarnings & Results

DANAHER CORP /DE/ 8-K Report, Financial Results (Jan 13, 2020)

Filed January 13, 2020For Securities:DHR

Summary

Danaher Corporation (DHR) filed an 8-K on January 13, 2020, to provide anticipated financial performance for the fourth quarter of 2019 ahead of its presentation at the J.P. Morgan Healthcare Conference. While the filing does not contain definitive Q4 2019 results, it signals management's intent to discuss performance and outlook. Investors should pay close attention to the J.P. Morgan Healthcare Conference presentation for specific financial details and forward-looking statements, as this 8-K serves primarily as a precursor to that event.

Key Highlights

  • 1Danaher Corporation (DHR) released an 8-K on January 13, 2020, related to its anticipated Q4 2019 financial performance.
  • 2The announcement precedes a scheduled presentation at the J.P. Morgan Healthcare Conference on January 14, 2020.
  • 3The 8-K incorporates a press release titled 'Danaher CEO to Comment on Financial Performance'.
  • 4This filing serves as a notification and a preliminary communication of financial expectations.
  • 5Specific financial results for Q4 2019 are not detailed within this 8-K but are expected to be disclosed during the conference presentation.
  • 6The information provided is not considered 'filed' for certain regulatory purposes until expressly incorporated into a future filing.

Frequently Asked Questions

The primary purpose of this 8-K filing is to inform investors that Danaher Corporation will be commenting on its anticipated financial performance for the fourth quarter of 2019 during its presentation at the J.P. Morgan Healthcare Conference.

No, this 8-K filing does not provide specific financial results for Q4 2019. It only announces that the company will be discussing its anticipated performance. The detailed financial information is expected to be released during the J.P. Morgan Healthcare Conference presentation.

The actual Q4 2019 financial results and further details are expected to be disclosed during Danaher Corporation's presentation at the J.P. Morgan Healthcare Conference on January 14, 2020. Investors should refer to the materials and webcast from that event.

This statement means that the content of this 8-K, specifically the press release referenced, is being furnished to the SEC for informational purposes rather than being officially 'filed' under certain sections of the Securities Exchange Act of 1934. This typically exempts it from liability under Section 18, unless it is specifically incorporated by reference into a later registration statement or annual/quarterly report.